Superworth

Pro DEX price to sales ratio PDEX

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026
2.6×
10-year median
1.8×
Against its 10-year history
82nd
percentile: 0 is its lowest day, 100 its highest
10-year range
0.8× to 4.5×
Peer median
1.6×

Pro DEX's price to sales ratio is 2.6× as of Oct 23, 2026.

That is above its ten-year median of 1.8×, higher than on 82% of days in the last ten years.

Over that time it ranged from 0.8× in Nov 2016 to 4.5× in Dec 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 1.6×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far2.6×1.7×3.0×
20251.8×1.3×3.5×
20242.8×1.2×3.1×
20231.3×1.1×1.4×
20221.3×1.3×2.3×
20212.2×1.9×3.5×
20203.3×1.9×4.5×
20192.4×1.7×2.9×
20182.2×1.2×2.5×
20171.3×0.9×1.5×
20160.9×0.6×1.3×
20150.7×0.7×1.0×
20140.9×0.6×1.1×
20130.7×0.4×0.7×
20120.4×0.3×0.4×

Against its peers

Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.

CompanyPrice to sales ratio
PDEXPro DEX2.6×
UTMDUtah Medical Products6.5×
INFUInfuSystem1.9×
EMBCEmbecta0.4×
KEQUKewaunee Scientific0.3×
TCMDTactile Systems Technology1.5×
MDXGMimedx1.6×
APTAlpha Pro Tech0.9×
MOVMovado1.0×
NEPHNephros1.9×
IRMDIradimed12.7×
Peer median1.6×

Where Pro DEX ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Pro DEX

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.